In a significant step towards tackling one of the UK’s most underdiagnosed conditions, North East and North Cumbria ...

With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the ...

AbbVie’s Elahere (mirvetuximab soravtansine) has been approved by the Medicines and Healthcare products Regulatory Agency ...